Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells

Biochemistry, Genetics and Molecular Biology

• Cancer Cell 100%
• Phosphoinositide 3-Kinase 66%
• Western Blotting 66%
• Drug Resistance 66%
• Fibrinogen 66%
• Zymography 66%
• extracellular signal regulated kinase 66%
• Epidermal Growth Factor Receptor 66%
• Transfection 33%
• Small Interfering RNA 33%
• MTT Assay 33%
• Reverse Transcription Polymerase Chain Reaction 33%
• Flow Cytometry 33%
• Doxorubicin 33%
• Mouse Model 33%
• Agonist 33%
• DNA Fragmentation 33%
• Gelatinase B 33%
• MMP9 33%
• Gelatinase A 33%
• MMP2 33%
• Enzyme Activity 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Breast Cancer 100%
• Chemotherapy 100%
• Malignant Neoplasm 50%
• Epidermal Growth Factor Receptor 50%
• Western Blot 50%
• Small Interfering RNA 50%
• Mitogen Activated Protein Kinase 50%
• Drug Resistance 50%
• Phosphatidylinositol 3 Kinase 50%
• Fibrinogen 50%
• Gelatin 50%
• Doxorubicin 25%
• Mouse Model 25%
• Recurrent Disease 25%
• Flow Cytometry 25%
• Receptor 25%
• Gelatinase A 25%
• 3 (4,5 Dimethyl 2 Thiazolyl) 2,5 Diphenyltetrazolium Bromide 25%
• Gelatinase B 25%

Medicine and Dentistry

• Cancer Cell 100%
• Breast Cancer 100%
• Chemotherapy 100%
• Western Blotting 16%
• Metastatic Carcinoma 16%
• Phosphoinositide 3-Kinase 16%
• Fibrinogen 16%
• extracellular signal regulated kinase 16%
• Small Interfering RNA 16%
• Gelatin 16%
• Drug Resistance 16%
• In Vitro 8%
• Receptor 8%
• Genetic Transfection 8%
• Recurrent Disease 8%
• Malignant Neoplasm 8%
• Gelatinase B 8%
• MTT Assay 8%
• Gelatinase A 8%
• Reverse Transcription Polymerase Chain Reaction 8%
• Breast Cancer Cell Line 8%
• Doxorubicin 8%
• Flow Cytometry 8%
• Enzyme Activity 8%